Actively Recruiting
Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA)
Led by University Hospital, Clermont-Ferrand · Updated on 2025-08-14
340
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The transition to parenthood is a critical period for both the woman and her partner, and this can affect the mental health of the parents. Like mothers, fathers are at risk of stress, anxiety, depression and post-traumatic stress disorder during the perinatal period. Existing screening or diagnostic tools have been developed on the basis of traditional depressive symptoms expressed by women. However, the manifestations of perinatal mental disorders appear to be different in men. It is therefore essential to develop tools that are sensitive and specific to both gender and the perinatal period in order to increase the sensitivity and specificity of screening for fathers. In France, to the best of the knowledge of the investigators, there is no validated tool in French to assess paternal psychological disorders, either prenatally or postnatally. Baldoni et al. had validated a brief self-report questionnaire, the " Perinatal Assessment of Paternal Affectivity " (PAPA), to screen for perinatal signs and symptoms of paternal affective disorder, using a gender-sensitive approach. The aim of this study is to cross-cultural adapt the PAPA in French and to evaluate its psychometric properties. This validation of the French-PAPA would provide a simple tool, easy to use in everyday practice, to detect any signs or symptoms of paternal psychopathological distress in the pre- and postnatal period.
CONDITIONS
Official Title
Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Woman and her male partner aged 18 years old and older
- Couple must understand, speak, and read French
- Couple must voluntarily give informed consent to participate
You will not qualify if you...
- Woman without a male partner
- Woman admitted to intensive care after giving birth
- Couple whose newborn died around the time of birth
- Couple who have experienced medical abortion or fetal death in utero for the current pregnancy
- Woman and/or male partner refusing to participate
- Woman and/or male partner not speaking French
- Woman and/or male partner unable to complete questionnaires
- Woman and/or male partner under guardianship, deprived of liberty, or in correctional custody
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Clermont-Ferrand
Clermont-Ferrand, France
Actively Recruiting
Research Team
L
Lise Laclautre
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here